• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

并通过调节小鼠肠道微生物群来减弱胆碱诱导的血浆三甲胺 N-氧化物的产生。

and Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

出版信息

Nutrients. 2022 Mar 14;14(6):1222. doi: 10.3390/nu14061222.

DOI:10.3390/nu14061222
PMID:35334879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8950610/
Abstract

Atherosclerosis is the main cause of myocardial infarction and stroke, and the morbidity and mortality rates of cardiovascular disease are among the highest of any disease worldwide. Excessive plasma trimethylamine-N-oxide (TMAO), an intestinal metabolite, promotes the development of atherosclerosis. Therefore, effective measures for reducing plasma TMAO production can contribute to preventing atherosclerosis. Probiotics are living microorganisms that are beneficial to the human body, and some of them can attenuate plasma TMAO production. To explore the effects of probiotic supplementation on plasma TMAO in choline-fed mice, we intragastrically administered eight strains of and eight strains of to mice for 6 weeks. Bb4 and BL1 and BL7 significantly reduced plasma TMAO and plasma and cecal trimethylamine concentrations. However, hepatic flavin monooxygenase (FMO) activity, flavin-containing monooxygenase 3 (FMO3), farnesoid X receptor (FXR) protein expression and TMAO fractional excretion were not significantly affected by supplementation. The treatment of strains modulated the abundances of several genera such as UCG-009, UCG-010, which belong to the Firmicutes that has been reported with gene clusters, which may be related to the reduction in intestinal TMA and plasma TMAO. Additionally, a reduction in indicates a reduction in circulating glucose and lipids, which may be another pathway by which strains reduce the risk of atherosclerosis. The effect of strains on also suggests a relationship between the abundance of this genus and TMA concentrations in the gut. Therefore, the mechanism underlying these changes might be gut microbiota regulation. These strains may have therapeutic potential for alleviating TMAO-related diseases.

摘要

动脉粥样硬化是心肌梗死和中风的主要原因,心血管疾病的发病率和死亡率在全球所有疾病中是最高的。肠道代谢产物过多的血浆三甲胺氧化物(TMAO)会促进动脉粥样硬化的发展。因此,减少血浆 TMAO 产生的有效措施有助于预防动脉粥样硬化。益生菌是对人体有益的活体微生物,其中一些可以减弱血浆 TMAO 的产生。为了探索益生菌补充对胆碱喂养小鼠血浆 TMAO 的影响,我们将 8 株 和 8 株 灌胃小鼠 6 周。Bb4 和 BL1 和 BL7 显著降低了血浆 TMAO 以及血浆和盲肠三甲胺浓度。然而,肝黄素单加氧酶(FMO)活性、黄素单加氧酶 3(FMO3)、法尼醇 X 受体(FXR)蛋白表达和 TMAO 分数排泄不受 补充的显著影响。 菌株的处理调节了几个属的丰度,如 UCG-009、UCG-010,它们属于Firmicutes,已报道与 基因簇有关,这可能与肠道 TMA 和血浆 TMAO 的减少有关。此外, 减少表明循环葡萄糖和脂质减少,这可能是 菌株降低动脉粥样硬化风险的另一种途径。 菌株对 的影响也表明该属的丰度与肠道中 TMA 浓度之间存在关系。因此,这些变化的机制可能是肠道微生物群的调节。这些 菌株可能具有缓解与 TMAO 相关疾病的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/d79c03001e3e/nutrients-14-01222-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/e8ba2e07785c/nutrients-14-01222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/9fa1fd3d6fb1/nutrients-14-01222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/f48734b4d143/nutrients-14-01222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/cf5dd21b2eba/nutrients-14-01222-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/a60687be4928/nutrients-14-01222-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/bf4a1b6ab60f/nutrients-14-01222-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/55dfcf25aba8/nutrients-14-01222-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/d79c03001e3e/nutrients-14-01222-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/e8ba2e07785c/nutrients-14-01222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/9fa1fd3d6fb1/nutrients-14-01222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/f48734b4d143/nutrients-14-01222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/cf5dd21b2eba/nutrients-14-01222-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/a60687be4928/nutrients-14-01222-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/bf4a1b6ab60f/nutrients-14-01222-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/55dfcf25aba8/nutrients-14-01222-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761d/8950610/d79c03001e3e/nutrients-14-01222-g008.jpg

相似文献

1
and Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice.并通过调节小鼠肠道微生物群来减弱胆碱诱导的血浆三甲胺 N-氧化物的产生。
Nutrients. 2022 Mar 14;14(6):1222. doi: 10.3390/nu14061222.
2
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶,可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
3
Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.植物乳杆菌 ZDY04 通过调节小鼠肠道微生物群表现出菌株特异性降低 TMAO 的特性。
Food Funct. 2018 Aug 15;9(8):4299-4309. doi: 10.1039/c8fo00349a.
4
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.白藜芦醇通过重塑肠道微生物群调节氧化三甲胺(TMAO)合成和胆汁酸代谢,减轻TMAO诱导的动脉粥样硬化。
mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15.
5
Dietary Methionine Restriction Alleviates Choline-Induced Tri-Methylamine-N-Oxide (TMAO) Elevation by Manipulating Gut Microbiota in Mice.饮食中蛋氨酸限制通过调控小鼠肠道微生物群减轻胆碱诱导的氧化三甲胺(TMAO)升高。
Nutrients. 2023 Jan 1;15(1):206. doi: 10.3390/nu15010206.
6
Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis.益生菌减少肠道三甲胺可改善与动脉粥样硬化相关的脂质代谢紊乱。
Nutrition. 2020 Nov-Dec;79-80:110941. doi: 10.1016/j.nut.2020.110941. Epub 2020 Jul 11.
7
Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.PSRC1 缺乏通过操纵肠道微生物群和黄素单加氧酶 3 增加 TMAO 生成来加速动脉粥样硬化。
Gut Microbes. 2022 Jan-Dec;14(1):2077602. doi: 10.1080/19490976.2022.2077602.
8
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
9
Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.小分子抑制肠道微生物胆碱三甲基胺裂解酶活性改变宿主胆固醇和胆汁酸代谢。
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1474-H1486. doi: 10.1152/ajpheart.00584.2019. Epub 2020 Apr 24.
10
Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.六氢吡啶抑制肠道微生物对胆碱的代谢及其相关心血管风险。
J Pharm Biomed Anal. 2018 Sep 10;159:100-112. doi: 10.1016/j.jpba.2018.06.027. Epub 2018 Jun 28.

引用本文的文献

1
Reducing redundancy and enhancing accuracy through a phylogenetically-informed microbial community metabolic modeling approach.通过系统发育信息微生物群落代谢建模方法减少冗余并提高准确性。
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf328.
2
Effects of prebiotics and phytochemicals on serum trimethylamine N-oxide reduction and gut microbiota: a systematic review and meta-analysis.益生元和植物化学物质对血清氧化三甲胺还原及肠道微生物群的影响:一项系统评价和荟萃分析
J Transl Med. 2025 Jul 9;23(1):759. doi: 10.1186/s12967-025-06806-7.
3
The Role of Oxidative Stress in Ischaemic Stroke and the Influence of Gut Microbiota.

本文引用的文献

1
Physiological Role of Bile Acids Modified by the Gut Microbiome.由肠道微生物群修饰的胆汁酸的生理作用。
Microorganisms. 2021 Dec 30;10(1):68. doi: 10.3390/microorganisms10010068.
2
Molecular Identification and Selection of Probiotic Strains Able to Reduce the Serum TMAO Level in Mice Challenged with Choline.能够降低胆碱刺激的小鼠血清氧化三甲胺水平的益生菌菌株的分子鉴定与筛选
Foods. 2021 Nov 27;10(12):2931. doi: 10.3390/foods10122931.
3
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy.肠道代谢物氧化三甲胺与动脉粥样硬化:从机制到治疗
氧化应激在缺血性卒中中的作用及肠道微生物群的影响
Antioxidants (Basel). 2025 Apr 30;14(5):542. doi: 10.3390/antiox14050542.
4
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health.氧化三甲胺(TMAO)作为一种后起之秀的代谢物:对人类健康的影响
Metabolites. 2025 Mar 24;15(4):220. doi: 10.3390/metabo15040220.
5
The microbiome-derived metabolite trimethylamine N-oxide is associated with chronic kidney disease risk.微生物群衍生的代谢物氧化三甲胺与慢性肾脏病风险相关。
Appl Microbiol Biotechnol. 2025 Apr 22;109(1):97. doi: 10.1007/s00253-025-13481-7.
6
The microbial metabolite trimethylamine N-oxide and the kidney diseases.微生物代谢产物氧化三甲胺与肾脏疾病
Front Cell Infect Microbiol. 2025 Mar 11;15:1488264. doi: 10.3389/fcimb.2025.1488264. eCollection 2025.
7
Advancements in the investigation of gut microbiota-based strategies for stroke prevention and treatment.基于肠道微生物群的中风预防和治疗策略的研究进展。
Front Immunol. 2025 Mar 4;16:1533343. doi: 10.3389/fimmu.2025.1533343. eCollection 2025.
8
Disorders of gut microbiota and fecal-serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus.肠道微生物群紊乱和粪便-血清代谢模式与肺结核及肺结核合并2型糖尿病相关。
Microbiol Spectr. 2025 Aug 5;13(8):e0177224. doi: 10.1128/spectrum.01772-24. Epub 2025 Mar 14.
9
Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis.肠道微生物群代谢产物氧化三甲胺对心血管疾病的影响:一项文献计量分析
Front Microbiol. 2025 Jan 6;15:1491731. doi: 10.3389/fmicb.2024.1491731. eCollection 2024.
10
Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke.肠道微生物衍生代谢物三甲胺 N-氧化物与缺血性脑卒中。
Biomolecules. 2024 Nov 18;14(11):1463. doi: 10.3390/biom14111463.
Front Cardiovasc Med. 2021 Nov 23;8:723886. doi: 10.3389/fcvm.2021.723886. eCollection 2021.
4
Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial.短双歧杆菌 CCFM1025 通过调节肠道微生物组和色氨酸代谢减轻重度抑郁症:一项随机临床试验。
Brain Behav Immun. 2022 Feb;100:233-241. doi: 10.1016/j.bbi.2021.11.023. Epub 2021 Dec 4.
5
Quantitative Detection of Strains in Feces Using Strain-Specific Primers.使用菌株特异性引物对粪便中的菌株进行定量检测。
Microorganisms. 2021 May 28;9(6):1159. doi: 10.3390/microorganisms9061159.
6
Isolated from Different Hosts Modifies the Intestinal Microbiota and Displays Differential Metabolic and Immunomodulatory Properties in Mice Fed a High-Fat Diet.从不同宿主中分离出来会改变肠道微生物群,并在高脂肪饮食喂养的小鼠中显示出不同的代谢和免疫调节特性。
Nutrients. 2021 Mar 21;13(3):1017. doi: 10.3390/nu13031017.
7
Diversity of Gut Microbiota and Bifidobacterial Community of Chinese Subjects of Different Ages and from Different Regions.不同年龄和不同地区中国人群的肠道微生物群和双歧杆菌群落的多样性
Microorganisms. 2020 Jul 24;8(8):1108. doi: 10.3390/microorganisms8081108.
8
Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.青春双歧杆菌和鼠李糖乳杆菌通过调节不同的肠道微生物群依赖的途径缓解高脂肪、高胆固醇饮食诱导的非酒精性脂肪肝疾病。
Food Funct. 2020 Jul 1;11(7):6115-6127. doi: 10.1039/c9fo02905b. Epub 2020 Jun 23.
9
Trimethylamine, a Toxic Precursor of Trimethylamine Oxide, Lost in Medical Databases.三甲胺,氧化三甲胺的一种有毒前体,在医学数据库中缺失。
J Nutr. 2020 Feb 1;150(2):419. doi: 10.1093/jn/nxz265.
10
Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production.精准的微生物组调节与离散膳食纤维结构直接影响短链脂肪酸的产生。
Cell Host Microbe. 2020 Mar 11;27(3):389-404.e6. doi: 10.1016/j.chom.2020.01.006. Epub 2020 Jan 30.